Aims: This study assessed the prevalence of substance use among Iranian patients with nephrologic disease (chronic renal failure) who were admitted in different nephrologic wards at Shiraz general hospitals. Design: Cross-sectional survey using structured interview and also using DSM-IV criteria for substance dependency. Setting: General hospitals in Shiraz city (patients with nephrologic disease admitted in different nephrologic wards). Participants: 64 (32 men and 32 women) patients selected randomly. Findings: Data were gathered by a structured interview from 64 patients admitted in nephrologic wards of general hospitals in 2001. The mean age was 49.39 years (SD = 19.62) ranging from 18 to 80 years. 26 (40.6%) of the subjects (65.6% of the men and 15.6% of the women) reported the use of substance(s) once or more in their lives. The majority, 23 (35.9%) used tobacco, 9 (14.1%) used opium and 2 (3.1%) used alcohol. None had used cannabis, heroin, cocaine or LSD. 20 (31.3%) of the subjects (50% of the men and 12.5% of the women) were currently substance dependent, using DSM-IV criteria. The majority, 18 (28.1%) were nicotine dependent, and 6 (9.4%) were opium dependent. There was a nonsignificant relationship between income or occupation or education and prevalence of substance use. The reported reasons for initial use of substance(s), in order of frequency, were enjoyment, modeling and release of tension, and also for current users were, habit, enjoyment and need. Conclusions: Substance use especially cigarettes, opium and alcohol was found to be high among patients. There was no report of cannabis, heroin, cocaine or LSD use. Cultural attitudes toward substance use were found to affect the type and amount of use. These findings can be considered when planning preventive or therapeutic programs.

Keywords:
Substance use, Nephrologic patients, Iranian
This content is only available via PDF.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.